Clinical Trials Sponsored by Dr Alex Duval Fondation Jean Dausset CEPH
Total 1 results
-
ANRS, Emerging Infectious DiseasesUniversity Hospital, Grenoble; Hopital Antoine Beclere; Dr Yassine Taoufik Dr... and other collaboratorsCompleted
Sponsors and Collaborators
- PETROSYAN Andreanik
- Notitia Biotechnologies Company
- Prof. OTTO Beisheim Stiftung (Germany)
- Health Pharma Professional Research
- Livivos, Inc.
- Andre Tsin Chih Chen
- Riverview Health Centre Foundation
- Antonio Martín Duce
- Ayse Cal
- The Finnish Hearth Association
- Beijing Municipal Education Commission
- CP-foreningen
- Semyung University Affiliated Oriental Medical Hospital
- Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- Neijiang Center for Disease Control and Prevention
- The Third Hospital of HanDan
- Oblikue Consulting
- ICE Intelligent Healthcare Co., Ltd
- Hyben Vital ApS
- Semler Scientific
- View Full List
Medical Conditions
- Under-eyes Dark Circles
- Refractory Oropharyngeal Squamous Cell Carcinoma
- Weight Loss Trajectory
- Male Patients
- Systemic Nickel Allergic Syndrome
- Visual Field Defect Homonymous Bilateral
- Adult T Lymphoblastic Lymphoma
- Non-Melanomatous Skin Cancer
- The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase
- Acute T Lymphoblastic Leukemia (T-ALL)
- Muscle Stretching Exercise; Postural Balance; Stabilometry; Platform
- Chronic Heart Disease
- Sprain of Sacroiliac Ligament
- TGF-β
- GI Bleed
- Medication Induced Acute Pancreatitis
- Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)
- Peritoneal Dialysis-related Infection
- Invasive Group A Streptococcal Disease
- Chemotherapy-Induced Peripheral Neuropathy (CIPN)
- View Full List
Drug Interventions
- VENLAFAXINE TABLETS 50 mg , single dose
- BAY2327949
- Eupatilin
- Edetate Calcium Disodium
- Ibuprofen
- NMDAE plus AIFA
- Combination of sitagliptin+ gemcitabine + nab-paclitaxel
- Aspirin, acetaminophen and caffeine
- Pomalidomide
- Formulation C ODT tablet 50 mg
- SGN-00101
- Etidronate
- LBP-EC01 0.01x IV Dose
- Buprenorphine transdermal patch
- CAT 2003
- Dasatinib
- Ginseng
- Other treatments
- Moxifloxacin (positive control)
- Casodex and Zoladex (or Lupron)
- View Full List
CROs by country
- Contract Research Organizations in Burundi
- Contract Research Organizations in Canada
- Contract Research Organizations in Denmark
- Contract Research Organizations in Georgia
- Contract Research Organizations in Guatemala
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Tunisia
- Contract Research Organizations in Uganda
- Contract Research Organizations in Vietnam
- CRO list by country